US 11964021
Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors
granted A61KA61K47/46A61K47/6849
Quick answer
US patent 11964021 (Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors) held by EnGeneIC Molecular Delivery Pty Ltd expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- EnGeneIC Molecular Delivery Pty Ltd
- Grant date
- Tue Apr 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K47/46, A61K47/6849, A61K51/1203, A61K9/5068